Dulcolax is considered safe to use while breastfeeding. The active ingredient, bisacodyl, is poorly absorbed into the bloodstream, and a study in lactating women found that the drug’s active compound was undetectable in breast milk at all tested doses. Both the NHS and major drug safety databases confirm that bisacodyl can be used during breastfeeding without special precautions.
Why Bisacodyl Doesn’t Reach Breast Milk
Bisacodyl works locally in the gut. When you take it as an oral tablet, only about 5 to 9 percent of the dose is absorbed into your bloodstream. With a suppository, that number drops even further, to roughly 3 percent. Once absorbed, the body converts bisacodyl into an active metabolite that does the actual work of stimulating your bowels.
A study published in Drug Metabolism and Pharmacokinetics tested breast milk samples from healthy lactating women who took 10 mg of bisacodyl daily over multiple days. The active metabolite remained below the detection limit (1 nanogram per milliliter) in every single sample, from every participant, on every study day. Researchers couldn’t even calculate how much transferred because there was nothing to measure. This is about as reassuring as the data gets for any medication during breastfeeding.
Even in a hypothetical scenario where trace amounts did reach breast milk, the compound would also be poorly absorbed from your baby’s gut, adding a second layer of protection. The NHS Specialist Pharmacy Service notes that infant side effects are “not expected” for this reason.
Tablets vs. Suppositories
Dulcolax comes in two forms: enteric-coated tablets and rectal suppositories. Both are considered compatible with breastfeeding. The suppository actually has lower systemic absorption (about 3 percent vs. up to 9 percent for oral tablets), so if anything, it introduces even less into your system. Suppositories also tend to work faster, typically producing a bowel movement within 15 to 60 minutes, while oral tablets are designed to work overnight, usually within 6 to 12 hours.
Some Dulcolax products sold in certain countries contain sodium picosulfate instead of bisacodyl. The same breast milk study tested sodium picosulfate alongside bisacodyl, and it produced identical results: the active metabolite was undetectable in milk. So regardless of which Dulcolax formulation you have, the safety profile is the same.
Practical Tips for Use
The NHS recommends trying dietary and lifestyle changes first: more fiber, plenty of water, and gentle movement. Postpartum constipation is extremely common, especially after a cesarean delivery or if you’re taking iron supplements, and these measures resolve many cases on their own.
When you do use Dulcolax, keep it to the shortest duration needed. This isn’t because of breastfeeding concerns specifically. Stimulant laxatives in general can cause cramping and, with prolonged daily use over weeks, your bowel can start to depend on them. For occasional constipation relief, a few days of use is typical and well-tolerated.
As a general precaution, the NHS Specialist Pharmacy Service suggests keeping an eye on your baby for loose stools or unusual fussiness, though they note that side effects are not expected based on the available evidence. If your baby’s pattern stays normal, there’s nothing further to watch for.
Other Laxative Options While Nursing
If you prefer to start with something gentler, bulk-forming laxatives (like psyllium husk) and osmotic laxatives (like polyethylene glycol or lactulose) are also compatible with breastfeeding and are often recommended as first-line options for postpartum constipation. These work by drawing water into the stool or adding bulk, rather than stimulating the intestinal muscles directly. They tend to cause less cramping but take longer to work, sometimes one to three days for full effect.
Stool softeners are another common choice in the postpartum period and are similarly considered safe during breastfeeding. Many hospitals offer them routinely after delivery. For persistent constipation that doesn’t respond to these options, bisacodyl provides a stronger, faster-acting alternative without meaningful risk to your nursing infant.